Gynecologic oncology Clinical Trials in Houston, TX

As of July 2026, 81 paid clinical trials are recruiting for Gynecologic oncology in Houston, Texas. Gynecologic oncology studies test PARP inhibitors, antibody-drug conjugates, maintenance therapies, and immune checkpoint inhibitors for ovarian, endometrial, cervical, and other gyn cancers. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

81 clinical trials for Gynecologic oncology

·Clear filters·↓ Download CSV

A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

for Ovarian Cancer Recurrent

Sites in Houston +3 more locations

Sponsor: Outpace Bio, Inc.

Sex: Female·Age: 18+

Code: NCT07030907·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma (HNSCC)

Sites in Houston +3 more locations

Sponsor: Tanabe Pharma America, Inc.

Sex: All·Age: 18+

Code: NCT06943521·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

for Salivary Gland Tumor

Sites in Houston +2 more locations

Sponsor: Avacta Life Sciences Ltd

Sex: All·Age: 18+

Code: NCT04969835·Phase 1·Recruiting·Listed Jul 2021

Apply to this trial

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

for Advanced Malignant Neoplasm

Sites in Houston +3 more locations

Sponsor: AtlasMedx, Incorporated

Sex: All·Age: 18+

Code: NCT04503265·Phase 1, Phase 2·Recruiting·Listed Aug 2020

Apply to this trial

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

for Solid Tumor, Adult

Sites in Houston, Dallas +2 more locations

Sponsor: Bio-Path Holdings, Inc.

Sex: All·Age: 18+

Code: NCT04196257·Phase 1·Recruiting·Listed Dec 2019

Apply to this trial

Comprehensive Outcomes for After Cancer Health

for Ovarian Cancer

Sites in Houston +3 more locations

Sponsor: Pack Health

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05349227·Recruiting·Listed Apr 2022

Apply to this trial

TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors

for Renal Cell Cancer

Sites in Houston +2 more locations

Sponsor: Portage Biotech

Sex: All·Age: 18+

Code: NCT04969315·Phase 1, Phase 2·Recruiting·Listed Jul 2021

Apply to this trial

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer

for Levonorgestrel

2 locations in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT07382583·Recruiting·Listed Feb 2026

Apply to this trial

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

for Endometrial Cancer

Sites in Houston +71 more locations

Sponsor: Canadian Cancer Trials Group

Sex: Female·Age: 18+

Code: NCT05640999·Phase 2·Recruiting·Listed Dec 2022

Apply to this trial

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for Fallopian Tube Endometrioid Adenocarcinoma

Drug: Bevacizumab

Sites in Houston, The Woodlands +643 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT06580314·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for Ovarian Carcinoma

Sites in Houston +472 more locations

Sponsor: NRG Oncology

Sex: Female·Age: 35 - 50

Code: NCT04251052·Recruiting·Listed Jan 2020

Apply to this trial

Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women

for Endometrial Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT06409052·Recruiting·Listed May 2024

Apply to this trial

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

for Colitis

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT04038619·Phase 1·Recruiting·Listed Jul 2019

Apply to this trial

BOLSTER: Learning New Skills to Thrive

for Gastrointestinal Cancer

Sites in Houston +1 more location

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT06936878·Recruiting·Listed Apr 2025

Apply to this trial

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

for Ovarian Cancer

Sites in Houston +8 more locations

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT05287451·Recruiting·Listed Mar 2022

Apply to this trial

Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer

for Endometrial Cancer

Drug: Dostarlimab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT05819892·Phase 1·Recruiting·Listed Apr 2023

Apply to this trial

Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women

for Ovarian Cancer

Sites in Houston, San Antonio +8 more locations

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 50 - 74·Accepts healthy volunteers

Code: NCT00539162·Recruiting·Listed Oct 2007

Apply to this trial

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

for Colorectal Carcinoma

Sites in Houston +19 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 12 Months - 30

Code: NCT04851119·Phase 1, Phase 2·Recruiting·Listed Apr 2021

Apply to this trial

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

for Ovarian Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT05649072·Recruiting·Listed Dec 2022

Apply to this trial

A Study of Intra-operative Imaging in Women With Ovarian Cancer

for Ovarian Cancer

Sites in Houston +8 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female·Age: All ages

Code: NCT04878094·Phase 3·Recruiting·Listed May 2021

Apply to this trial

Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy

for Ovarian Cancer

Drug: Bevacizumab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT06083844·Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

for Endometrial Cancer

Sites in Houston, Katy +18 more locations

Sponsor: Mayo Clinic

Sex: Female·Age: 18+

Code: NCT05051722·Recruiting·Listed Sep 2021

Apply to this trial

Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)

for Ovarian Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT05123807·Phase 2·Recruiting·Listed Nov 2021

Apply to this trial

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

for Ovarian Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT06036810·Recruiting·Listed Sep 2023

Apply to this trial

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

for Breast Carcinoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT03604315·Phase 1·Recruiting·Listed Jul 2018

Apply to this trial

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

for BRCA1 Gene Mutation

Sites in Houston +10 more locations

Sponsor: University Medical Center Nijmegen

Sex: Female·Age: 25 - 50

Code: NCT04294927·Recruiting·Listed Mar 2020

Apply to this trial

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

for Oncology

Sites in Houston +2 more locations

Sponsor: UMC Utrecht

Sex: All·Age: 18+

Code: NCT04075305·Recruiting·Listed Aug 2019

Apply to this trial

Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

for Low Grade Ovarian Serous Adenocarcinoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: All ages

Code: NCT00488878·Recruiting·Listed Jun 2007

Apply to this trial

Rice Technologies for Cervical Cancer Screening and Diagnosis

for Cervical Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 25 - 49

Code: NCT05372484·Recruiting·Listed May 2022

Apply to this trial

Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer

for Ovarian Cancer

Drug: Lurbinectedin

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT05636111·Phase 1·Recruiting·Listed Dec 2022

Apply to this trial

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

for Endometrial Cancer

Sites in Houston +3 more locations

Sponsor: University of Chicago

Sex: Female·Age: 18+

Code: NCT04683653·Phase 1, Phase 2·Recruiting·Listed Dec 2020

Apply to this trial

Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer

for Ovarian Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT06545604·Recruiting·Listed Aug 2024

Apply to this trial

Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer

for ENDOMETRIAL CANCER

4 locations in Houston

Sponsor: Anthony Costales, MD

Sex: Female·Age: 18 - 90

Code: NCT04586959·Recruiting·Listed Oct 2020

Apply to this trial

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

for Endometrial Cancer

Sites in Houston, Austin +64 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT07044336·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for Endometrial Cancer

Drug: Rilvegostomig

Sites in Houston, Austin +43 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT06989112·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

for Breast Cancer

Sites in Houston +9 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT05123482·Phase 1, Phase 2·Recruiting·Listed Nov 2021

Apply to this trial

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

for Non-small Cell Lung Cancer

Sites in Houston, Round Rock +12 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT05877599·Phase 1·Recruiting·Listed May 2023

Apply to this trial

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

for Non-small Cell Lung Cancer

Sites in Houston, Galveston +16 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06218914·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for Endometrial Cancer

Sites in Houston +10 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05489211·Phase 2·Recruiting·Listed Aug 2022

Apply to this trial

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

for Ovarian Cancer

Sites in Houston +10 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05797168·Phase 1, Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

Conditions in Gynecologic oncology (Houston, TX)

Ovarian cancer· 55 Endometrial cancer· 39 Cervical cancer· 17 Fallopian tube cancer· 6 Gynecologic cancer· 3 Uterine cancer· 2